Center for Human Genetics, Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium
Center for Vascular Anomalies, Division of Plastic Surgery, Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium; VASCERN VASCA European Reference Center.
J Med Genet. 2020 Jan;57(1):48-52. doi: 10.1136/jmedgenet-2019-106024. Epub 2019 Jul 12.
Capillary malformation-arteriovenous malformation is an autosomal dominant disorder, characterised by capillary malformations and increased risk of fast-flow vascular malformations, caused by loss-of-function mutations in the or genes. Around 25% of the patients do not seem to carry a germline mutation in either one of these two genes. Even if other genes could be involved, some individuals may have mutations in the known genes that escaped detection by less sensitive techniques. We tested the hypothesis that mosaic mutations could explain some of previously negative cases.
DNA was extracted from peripheral blood lymphocytes, saliva or vascular malformation tissues from four patients. and coding regions and exon/intron boundaries were analysed by targeted custom gene panel sequencing. A second panel and/or Sanger sequencing were used to confirm the identified mutations.
Four distinct mosaic mutations, with an allele frequency ranging from 3% to 25%, were identified in four index patients with classical capillary malformation-arteriovenous malformation phenotype. Three mutations were known, one was novel. In one patient, a somatic second hit was also identified. One index case had three affected children, illustrating that the mosaicism was also present in the germline.
This study shows that mosaic mutations can cause capillary malformation-arteriovenous malformation. Thus, highly sensitive sequencing techniques should be considered as diagnostic tools, especially for patients with no family history. Even low-level mosaicism can cause the classical phenotype and increased risk for offspring. In addition, our study further supports the second-hit pathophysiological mechanism to explain the multifocality of vascular lesions in this disorder.
毛细血管畸形-动静脉畸形是一种常染色体显性遗传病,其特征为毛细血管畸形和快速流动血管畸形风险增加,这是由于 或 基因的功能丧失突变引起的。大约 25%的患者似乎在这两个基因中没有携带种系突变。即使其他基因可能参与其中,一些个体可能在已知基因中发生了突变,但这些突变未能通过敏感性较低的技术检测到。我们检验了这样一个假设,即镶嵌突变可以解释一些先前的阴性病例。
从四名患者的外周血淋巴细胞、唾液或血管畸形组织中提取 DNA。通过靶向定制基因panel 测序分析 和 编码区及外显子/内含子边界。使用第二个 panel 和/或 Sanger 测序来确认鉴定的突变。
在四名具有经典毛细血管畸形-动静脉畸形表型的索引患者中,鉴定出了四个不同的 镶嵌突变,等位基因频率在 3%到 25%之间。其中三个突变是已知的,一个是新的。在一名患者中,还鉴定出了一个体细胞的二次打击。一名索引病例有三个受影响的孩子,这表明镶嵌性也存在于种系中。
本研究表明, 镶嵌突变可导致毛细血管畸形-动静脉畸形。因此,高灵敏度测序技术应被视为诊断工具,特别是对于无家族史的患者。即使是低水平的镶嵌性也可导致经典表型和增加后代的发病风险。此外,我们的研究进一步支持了二次打击的病理生理机制,以解释该疾病血管病变的多灶性。